HK2 and neoplasm: To the best of our knowledge, for the first time, this study demonstrated that miR-505 functions as a tumor suppressor to attenuate glycolysis and aggressive phenotypes of PC cells through targeting HK2, and that oncogenic LINC01448 serves as an upstream inhibitor of miR-505 in PC cells (Figure 9).